key: cord-0979956-lpgtzqfm
authors: Rezaeitalab, Fariborz; Rezaeetalab, Fariba; Akbari, Farzaneh; Ata Sharifi Dalooei, Seyyed Mohammad; Saberi, Soheila; Mirtouni, Saeedeh S.
title: COVID-19: Non-Invasive Ventilation in Hypoxemic Acute Respiratory Failure
date: 2022-01-18
journal: Int J Prev Med
DOI: 10.4103/ijpvm.ijpvm_512_20
sha: bc5fcc157ad5140b8d8d373cbf529f93a150fe42
doc_id: 979956
cord_uid: lpgtzqfm

nan

The history, past travelling to endemic areas, contacting with infected patients, was suggestive for detecting of COVID-19. Positive real-time poly chain reaction (RT-PCR) for the virus is the definitive diagnostic test; however, a negative RT-PCR is not a ruled out disease. [5] At this time, we passed minimum 5 peaks of COVID-19 in Iran and 2 peaks in other parts of the world. Nowadays, there is no specific and definitive medication. [6] Effective vaccination against COVID-19 is the most important policy to prevent the spread of the virus and the global pandemic. [7] As the COVID-19 epidemic continued and patients died, researchers applied vaccination prevention. [8] Maintaining tissue oxygenation and preventing cell death are an important principle in approaching patients with respiratory failure of COVID-19 pneumonia. However, the late 1980s non-invasive ventilatory support (NIV) has become a standard treatment in acute exacerbation of COPD (AECOPD) with hypercapnia. Nevertheless,

NIV is an important device for COVID-19 with mild and moderate acute respiratory distress syndrome (ARDS) and hypoxemia. [8] The lesson that I learned from the visit of the critically ill patients with COVID-19 in the intensive care unite (ICU) is the application of high levels of positive end expiratory pressure (PEEP) in bilevel positive airway pressure (BiPAP) insertion. High expiratory pressure opens collapsed alveoli and decreases lung stiffness. [9] Conclusion As a COVID-19 spreads rapidly, many parts of the public world may be involved. We need to know that Corona virus lives with us, and that it could have deadly outbreaks in society. Hypoxemic respiratory failure is a dramatically presentation of COVID-19 with high mortality. NIV such as BIPAP with high expiratory pressure recommends for these patients.

Nil.

There are no conflicts of interest. 

Ophthalmologists are more than eye doctors-in memoriam Li Wenliang

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Clinical characteristics of corona virus disease 2019 in China

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study

Sensitivity of chest CT for COVID-19 comparison to RT-PCR

Management of COVID-19: The risks associated with treatment are clear, but the benefits remain uncertain

The development of COVID-19 vaccines: Safeguards needed

Viral targets for vaccines against COVID-19

Intubation and mechanical ventilation of patients with Covid -19: What should we tell them

COVID-19: Non-invasive ventilation in hypoxemic acute respiratory failure

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Quick Response Code:Website:www.ijpvmjournal.net/www.ijpm.ir

10.4103/ijpvm.IJPVM_512_20